-
EDITORIAL for Monday 6 February 2017
Welcome to the current edition of i2P (Information to Pharmacists) E-Magazine, dated Monday 6 February 2017. Just for a moment, imagine that you are a drug manufacturer and start to think about how you might promote your product range. You might think that a proactive approach might be to communicate your product benefits to the…
-
Planning for Uncertainty and Anxiety
To say that pharmacy began the current fiscal year with a high level of uncertainty – a major contributor to anxiety levels – is to state the obvious. Every person working within the pharmaceutical industry has been affected, with employed pharmacists complaining about the poor incomes they receive and fresh reports of a potential for…
-
Design for a Medication Safety Plan
The problem of creating a quality professional pharmacy practice for community pharmacy is often in conflict with the metrics required to provide a solid business infrastructure. Without a sound infrastructure there is no support to underpin a professional practice, so Codes of Conduct and minimum levels for Standards of Practice have to be developed. Increased…
-
Coincidence?
Medical media recently has highlighted the bad news for back pain sufferers – analgesic don’t work! As reported in 6minutes newsletter to GPs, “NSAIDs such as ibuprofen are no better than placebo. And perhaps do more harm than good.” The news release goes on to say that “previous research has already demonstrated that paracetamol is…
-
What can we learn from Thyroid Pharmacist?
It was just over a year ago, when I was starting out in a busy suburban pharmacy as a professional services pharmacist, when I noticed something a bit weird…literally every second person I spoke with for about a full week was on thyroxine tablets. I stared back at these patients. A lot of them were…
-
Understanding Medical Cannabis – What are the basic Components?
This article is one of a series planned for the provision of basic information relating to medical cannabis – a catch-all generic term for a range of cannabinoids that individually or collectively qualify for the terminology of medical cannabis. It can be confusing because that term is often used interchangeably with other names such as…
-
Vaccine Update – 1. Jon Rappoport 2. Freda Birrell (Sanevax) 3. Dr Judy Wilyman 4. Health Impact News
Editor’s Note: The strategies devised to market vaccines were primarily developed by Big Pharma’s in the US. That they have been proven to be deceptive, certainly unsafe for some vaccine products (due to toxic preservatives and adjuvants) and enforced by corrupt agencies of government – has left health professionals and health consumers quite bewildered and…
-
PSA Media Releases – 1. New EC Guide 2. PSA17 Conference 3. Pharmacists Honoured on Australia Day 4. New Practice Standards 5. Pre-Budget Submission
Informative new emergency contraception guide for pharmacists February 2, 2017 New guidelines and professional resources for registered pharmacists have been released by the peak national body for pharmacists, PSA, following changes to emergency contraception (EC) medicines in Australia. From February 1, 2017, pharmacists will now be able to supply ulipristal to women as a Pharmacist-Only…
-
ASMI Media Releases – 1. Three Steps to Better Consumer Health 2. Sunscreens High Standard 3. NSAID’s & Acute Pain
Three simple steps to better outcomes for consumers’ health and the economy 24 January 2017 The Australian Self Medication Industry (ASMI) has issued a trio of recommendations to the Federal Government outlining key mechanisms that will provide consumers with better access to information and medicines to self-manage their health, provide savings for the national healthcare…
-
NPS Media Releases – Latest Edition of Australian Prescriber
1 FEBRUARY 2017 Latest edition of Australian Prescriber out now The latest issue of Australia’s free, national, independent journal of drugs and therapeutics is now available. Australian Prescriber facilitates debate about complex, controversial or uncertain therapeutic areas. Some of the highlights of the February issue include: Drugs for chronic obstructive pulmonary disease Chronic obstructive pulmonary…